1. Home
  2. CENN vs AKTX Comparison

CENN vs AKTX Comparison

Compare CENN & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CENN
  • AKTX
  • Stock Information
  • Founded
  • CENN 2013
  • AKTX N/A
  • Country
  • CENN United States
  • AKTX United States
  • Employees
  • CENN N/A
  • AKTX N/A
  • Industry
  • CENN Auto Manufacturing
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CENN Consumer Discretionary
  • AKTX Health Care
  • Exchange
  • CENN Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • CENN 30.4M
  • AKTX 41.8M
  • IPO Year
  • CENN N/A
  • AKTX N/A
  • Fundamental
  • Price
  • CENN $0.75
  • AKTX $1.17
  • Analyst Decision
  • CENN
  • AKTX
  • Analyst Count
  • CENN 0
  • AKTX 0
  • Target Price
  • CENN N/A
  • AKTX N/A
  • AVG Volume (30 Days)
  • CENN 357.6K
  • AKTX 27.5K
  • Earning Date
  • CENN 08-12-2025
  • AKTX 08-18-2025
  • Dividend Yield
  • CENN N/A
  • AKTX N/A
  • EPS Growth
  • CENN N/A
  • AKTX N/A
  • EPS
  • CENN N/A
  • AKTX N/A
  • Revenue
  • CENN $31,097,533.00
  • AKTX N/A
  • Revenue This Year
  • CENN N/A
  • AKTX N/A
  • Revenue Next Year
  • CENN N/A
  • AKTX N/A
  • P/E Ratio
  • CENN N/A
  • AKTX N/A
  • Revenue Growth
  • CENN 234.45
  • AKTX N/A
  • 52 Week Low
  • CENN $0.64
  • AKTX $0.85
  • 52 Week High
  • CENN $1.84
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • CENN 41.07
  • AKTX 45.49
  • Support Level
  • CENN $0.66
  • AKTX $1.10
  • Resistance Level
  • CENN $0.79
  • AKTX $1.18
  • Average True Range (ATR)
  • CENN 0.09
  • AKTX 0.07
  • MACD
  • CENN -0.02
  • AKTX 0.00
  • Stochastic Oscillator
  • CENN 16.22
  • AKTX 53.25

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

Share on Social Networks: